FDA Oncology Announcements

MTOR inhibitor × CNS × Clear all

3 Announcements

FDA approves everolimus for tuberous sclerosis complex-associated partial-onset seizures

Trial: EXIST-3
Drugs: Afinitor Disperz (everolimus tablets for oral suspension) · MTOR inhibitor, Afinitor Disperz (oral suspension)
Condition: CNS

Everolimus for Tuberous Sclerosis Complex (TSC)

Drug: Afinitor Disperz (everolimus tablets for oral suspension) · MTOR inhibitor
Condition: CNS

Everolimus (Accelerated Approval)

Drug: Afinitor (everolimus) · MTOR inhibitor
Condition: CNS